TransMedics Group, Inc. TMDX Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Heart Product | $127.06M+9.2% | $126.01M+14.7% | $124.21M+21.1% | $120.55M+27.5% | $116.32M+46.0% | |
| Liver Product | $490.65M+39.6% | $460.53M+48.7% | $421.89M+53.2% | $390.62M+62.8% | $351.55M+79.7% | |
| Lung Product | $13.67M-14.7% | $14.86M-15.9% | $16.11M-7.7% | $15.91M-7.9% | $16.03M+1.4% | |
| Cost Of Revenue by Product | ||||||
| Product | $85.82M+41.7% | $77.82M+33.4% | $70.97M+27.0% | $65.52M+22.0% | $60.57M+26.7% | |
| Service | $174.33M+27.0% | $164.87M+36.1% | $153.98M+43.6% | $148.09M+69.7% | $137.31M+115% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does TransMedics Group, Inc. break its business down?
- TransMedics Group, Inc. (TMDX) reports revenue by product across 3 parts — Heart Product, Liver Product and Lung Product. Each is extracted from the segment footnotes and tracked over time.
- Where does TransMedics Group, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in TransMedics Group, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
